DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 12Dr. Reddy's Laboratories
02 2Actavis Inc
03 4Alembic Pharmaceuticals Limited
04 1Amneal Pharmaceuticals
05 1Amoli Organics
06 4Amomed Pharma GmbH
07 1Amomed Pharma Gmbh
08 1Amphastar Pharmaceuticals
09 12Ferrer Internacional
10 4Ferrer International, Sa.
11 4Gebro Pharma
12 4Ideogen Ag
13 4Liquidia Corporation
14 2Medartuum
15 4ORIFARM GROUP AS
16 4OrPha Swiss
17 4Orpha-Devel Handels Und Vertriebs Gmbh
18 4Orpha-Devel Handels und Vertriebs GmbH
19 4Orpha-Devel Trading And Sales Gmbh
20 4PH HEALTH
21 1Paranova Pharmaceuticals Ab
22 4Sandoz B2B
23 4Scipharm S.A.R.L.
24 4Scipharm S?rl
25 4Scipharm Sarl
26 4Teva Pharmaceutical Industries
27 4Tillomed Laboratories Ltd
28 26United Therapeutics
29 4Zentiva
01 28INJECTABLE;INTRAVENOUS, SUBCUTANEOUS
02 39Infusion Solution
03 4Injection
04 9POWDER;INHALATION
05 12Perfusion Solution
06 4SOLUTION
07 1SOLUTION;INHALATION
08 4SOLUTION;INTRAVENOUS, SUBCUTANEOUS
09 24Solution For Infusion
10 4Solution For Perfusion
11 2TABLET, EXTENDED RELEASE;ORAL
12 1Treprostinil 100Mg 20Ml 1 Units Parenteral Use
13 1Treprostinil 200Mg 20Ml 1 Units Parenteral Use
14 1Treprostinil 20Mg 20Ml 1 Units Parenteral Use
15 1Treprostinil 50Mg 20Ml 1 Units Parenteral Use
01 12Allowed
02 20Approved
03 4Authorised
04 16Authorized
05 11DISCN
06 7Deregistered
07 4Lead Market Dossiers- Filed
08 8Marketed
09 16Prescription
10 31RX
11 6Blank
01 16REMODULIN
02 27Remodulin
03 22TREPROSTINIL
04 1TYVASO
05 5TYVASO DPI
06 4Treprostinil Ferrer
07 4Treprostinil Ideogen
08 4Treprostinil Orpha
09 4Treprostinil Reddy
10 4Treprostinil Tillomed
11 4Treprostinilo Zentiva
12 12Trepulmix
13 16Tresuvi
14 4Wooden house
15 4YUTREPIA
16 4Blank
01 4Canada
02 12Estonia
03 4India
04 4Italy
05 4Malta
06 8Norway
07 16Spain
08 27Sweden
09 12Switzerland
10 44USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : TREPROSTINIL
Dosage Form : INJECTABLE;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 1MG/ML
Packaging :
Approval Date : 2020-05-22
Application Number : 210214
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : TREPROSTINIL
Dosage Form : INJECTABLE;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 2.5MG/ML
Packaging :
Approval Date : 2020-05-22
Application Number : 210214
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : TREPROSTINIL
Dosage Form : INJECTABLE;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 5MG/ML
Packaging :
Approval Date : 2020-05-22
Application Number : 210214
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : TREPROSTINIL
Dosage Form : INJECTABLE;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 10MG/ML
Packaging :
Approval Date : 2020-05-22
Application Number : 210214
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 1MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 2.5MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 5MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 10MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Treprostinil Reddy
Dosage Form : Infusion Solution
Dosage Strength : 1mg/ml
Packaging :
Approval Date : 26/01/2022
Application Number : 20200930000055
Regulatory Info : Approved
Registration Country : Sweden
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Treprostinil Reddy
Dosage Form : Infusion Solution
Dosage Strength : 10mg/ml
Packaging :
Approval Date : 26/01/2022
Application Number : 20200930000086
Regulatory Info : Approved
Registration Country : Sweden
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Treprostinil Reddy
Dosage Form : Infusion Solution
Dosage Strength : 2.5mg/ml
Packaging :
Approval Date : 26/01/2022
Application Number : 20200930000062
Regulatory Info : Approved
Registration Country : Sweden
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Treprostinil Reddy
Dosage Form : Infusion Solution
Dosage Strength :
Packaging :
Approval Date : 26/01/2022
Application Number : 20200930000079
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : RX
Registration Country : USA
Brand Name : REMODULIN
Dosage Form : INJECTABLE;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 1MG/ML
Packaging :
Approval Date : 2002-05-21
Application Number : 21272
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : REMODULIN
Dosage Form : INJECTABLE;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 2.5MG/ML
Packaging :
Approval Date : 2002-05-21
Application Number : 21272
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : REMODULIN
Dosage Form : INJECTABLE;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 5MG/ML
Packaging :
Approval Date : 2002-05-21
Application Number : 21272
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : REMODULIN
Dosage Form : INJECTABLE;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 10MG/ML
Packaging :
Approval Date : 2002-05-21
Application Number : 21272
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : REMODULIN
Dosage Form : INJECTABLE;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 20MG/ML
Packaging :
Approval Date : 2021-07-30
Application Number : 21272
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : REMODULIN
Dosage Form : INJECTABLE;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 0.1MG/ML
Packaging :
Approval Date : 2023-09-28
Application Number : 21272
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : REMODULIN
Dosage Form : INJECTABLE;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 0.2MG/ML
Packaging :
Approval Date : 2023-09-28
Application Number : 21272
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : REMODULIN
Dosage Form : INJECTABLE;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 0.4MG/ML
Packaging :
Approval Date : 2023-09-28
Application Number : 21272
Regulatory Info : RX
Registration Country : USA
